絞り込み

16733

広告

ジュゴン、沖縄の2島に生息か (デイリースポーツ)

環境省は31日、絶滅の恐れが極めて高いジュゴンが海草を食べたとみられる跡を、沖縄県の伊良部島と波照間島の沿岸で初めて確認したとの調査結果を発表した。姿を捉えるこ...

  1. 演歌歌手の加門亮さん 死去 (NHK)
  2. 新型コロナウイルス感染症の患者等の発生に...
  3. 新型コロナウイルス感染症の大規模な感染拡...
  4. 新型コロナウイルス感染症の現在の状況と厚...

ニュース一覧

Mitochondrial dysfunction in genetic animal models of Parkinson's disease.

著者 Trancikova A , Tsika E , Moore DJ
Antioxid Redox Signal.2012 May 1 ; 16(9):896-919.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

Laboratory of Molecular Neurodegenerative Research, Brain Mind Institute, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.

スターを付ける スターを付ける     (31view , 1users)

Full Text Sources

Medical

Miscellaneous

Mitochondria are highly dynamic, multifunctional organelles. Aside from their major role in energy metabolism, they are also crucial for many cellular processes including neurotransmission, synaptic maintenance, calcium homeostasis, cell death, and neuronal survival. SIGNIFICANCE: Increasing evidence supports a role for abnormal mitochondrial function in the molecular pathophysiology of Parkinson's disease (PD). For three decades we have known that mitochondrial toxins are capable of producing clinical parkinsonism in humans. PD is the most common neurodegenerative movement disorder that is characterized by the progressive loss of substantia nigra dopaminergic neurons leading to a deficiency of striatal dopamine. Although the neuropathology underlying the disease is well defined, it remains unclear why nigral dopaminergic neurons degenerate and die. RECENT ADVANCES: Most PD cases are idiopathic, but there are rare familial cases. Mutations in five genes are known to unambiguously cause monogenic familial PD: α-synuclein, parkin, DJ-1, PTEN-induced kinase 1 (PINK1), and leucine-rich repeat kinase 2 (LRRK2). These key molecular players are proteins of seemingly diverse function, but with potentially important roles in mitochondrial maintenance and function. Cell and animal-based genetic models have provided indispensable tools for understanding the molecular basis of PD, and have provided additional evidence implicating mitochondrial dysfunction as a primary pathogenic pathway leading to the demise of dopaminergic neurons in PD. CRITICAL ISSUES: Here, we critically discuss the evidence for mitochondrial dysfunction in genetic animal models of PD, and evaluate whether abnormal mitochondrial function represents a cause or consequence of disease pathogenesis. FUTURE DIRECTIONS: Mitochondria may represent a potential target for the development of disease-modifying therapies.
PMID: 21848447 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード